Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Molecular Imaging Branch (MIB)

2020 Publications

Full Refereed Papers

L. Cai, J.S. Liow, C.L. Morse, S. Telu, R. Davies, M.P. Frankland, , S.S. Zoghbi, K. Cheng, M.D. Hall, R.B. Innis, V.W. Pike, Evaluation of 11C-NR2B-SMe and its enantiomers as PET radioligands for imaging the NR2B Subunit within the NMDA receptor complex in rats. J. Nucl. Med. (2020) 61, 1212-1220. DOI:10.2967/jnumed.119.235143. https://pubmed.ncbi.nlm.nih.gov/31924728/ 

E.J. Jakobsson, S. Lu, S. Telu, V.W. Pike, [11C]Carbonyl difluoride‐a new and highly efficient [11C]carbonyl group transfer agent. Angew. Chem. Intl. Ed. (2020) 132, 7256-7260. DOI:10.1002/anie.201915414. https://pubmed.ncbi.nlm.nih.gov/31995256/ 

S. Lu, M.B. Haskali, K.M. Ruley, N.J.-F. Dreyfus, S.L. DuBois, J.S. Liow, C.L. Morse, A. Kowalski, R.L. Gladding, J. Gilmore, A.J. Mogg, S.M. Morin, P. Lindsay-Scott, V.N. Barth, H.N. Nuthall, M.P. Johnson, M. Cuadrado, E. Jambrina, S.S. Zoghbi, R.B. Innis, C.D. Jesudason, V.W. Pike, PET ligands [18F]LSN3316612 and [11C]LSN3316612 quantify O-linked-β-N-acetyl-glucosamine hydrolase in the brain. Sci. Transl. Med. (2020) 12, Article ID aau2939. (Featured on cover). DOI:10.1126/scitranslmed.aau2939. https://pubmed.ncbi.nlm.nih.gov/32404505/ 

G.M. Knudsen, M. Ganz, S. Appelhoff, R. Boellaard, G. Bormans, R.E. Carson, C. Catana, D. Doudet, A.D. Gee, D.N. Greve, R.N. Gunn, C. Halldin, P. Herscovitch, H. Huang, S.H. Keller, A.A. Lammertsma, R. Lanzenberger, J.S. Liow, T.G. Lohith, M. Lubberink, C.H. Lyoo, J.J. Mann, G.J. Matheson, T.E. Nichols, M. Nørgaard, T. Ogden, R. Parsey, V.W. Pike, J. Price, G. Rizzo, P. Rosa-Neto, M. Schain, P.J.H. Scott, G. Searle, M. Slifstein, T. Suhara, P.S. Talbot, A. Thomas, M. Veronese, D.F. Wong, M. Yaqub, F. Zanderigo, S. Zoghbi, R.B. Innis, Guidelines for the content and format of PET brain data in publications and archives: A consensus paper. J. Cereb. Blood Flow Metab. (2020) 40, 1576-1585. DOI:10.1177/0271678X20905433, https://pubmed.ncbi.nlm.nih.gov/32065076/ 

J.-H. Lee, J.S. Liow, S. Paul, C.L. Morse, M.B. Haskali, L. Manly, S. Shcherbinin, J.C. Ruble, N. Kant, E.C. Collins, H.N. Nuthall, P. Zanotti-Fregonara, S.S. Zoghbi, V.W. Pike, R.B. Innis, PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers. EJNMMI Res. (2020) 10, Article ID 20. DOI:10.1186/s13550-020-0616-4. https://pubmed.ncbi.nlm.nih.gov/32172476/ 

L.D. Weidner, Y. Wakabayashi, L.A. Stolz, M.T. Collins, L. Guthrie, M. Victorino, J. Chung, W. Miller, S.S. Zoghbi, V.W. Pike, M. Fujita, R.B. Innis, A.M. Boyce, PET imaging of phosphodiesterase-4 identifies affected dysplastic bone in McCune-Albright syndrome, a genetic mosaic disorder. J. Nucl. Med. (2020) 61, 1672-1677. DOI:10.2967/jnumed.120.241976. https://pubmed.ncbi.nlm.nih.gov/32284396/ 

M.-J. Kim, J.-H. Lee, F.J. Anaya, J. Hong, W. Miller, S. Telu, P. Singh, M.Y. Cortes, K. Henry, G.L. Tye, M.P. Frankland, J.A. Montero Santamaria, J.S. Liow, S.S. Zoghbi, M. Fujita, V.W. Pike, R.B. Innis, First-in human evaluation of [11C]PS13, a novel PET radioligand, to quantify cyclooxygenase-1 in the brain. Eur. J. Nucl. Med. Mol. Imaging. (2020) 47, 3143-3151. DOI:10.1007/s00259-020-04855-2. https://pubmed.ncbi.nlm.nih.gov/32399622/ 

S. Jana, S. Telu, B.Y. Yang, , M.B. Haskali,. J.E. Jakobsson, V.W. Pike, Rapid Syntheses of [11C]arylvinyltrifluoromethanes through treatment of (E)-arylvinyl(phenyl)iodonium tosylates with [11C]trifluoromethylcopper(I). Org. Lett. (2020) 22, 4574–4578. DOI:10.1021/acs.orglett.0c01705. https://pubmed.ncbi.nlm.nih.gov/32459101/ 

S. Shrestha, M.J. Kim, M. Eldridge, M.L. Lehmann, M. Frankland, J.S. Liow, Z-X. Yu, M. Cortes-Salva, S. Telu, I.D. Henter, E. Gallagher, J.-H. Lee, J.M. Fredericks, C. Poffenberger, G. Tye, Y. Ruiz-Perdomo, F.J. Anaya, J.A., Montero Santamaria R.L. Gladding, S.S. Zoghbi, M. Fujita, J.D. Katz, V.W. Pike, R.B. Innis, PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first in-human study. J. Neuroinflammation (2020) 17, Article ID 140. DOI:10.1186/s12974-020-01804-6. https://pubmed.ncbi.nlm.nih.gov/32359360/ 

K.M. Ramos-Torres, Y.-P. Zhou, B.Y. Yang, N.J. Guehl, S.H. Moon, S. Telu, M.D. Normandin, V.W. Pike, P. Brugaralos, Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for demyelinating diseases. RSC Med. Chem. (2020) 11, 1161-1167. (Featured on cover) DOI:10.1039/d0md00190b. https://pubmed.ncbi.nlm.nih.gov/33479620/ 

N. Young, , V.W. Pike, C. Taddei, Rapid and efficient synthesis of [11C]trifluoromethylarenes from primary aromatic amines with [11C]CuCF3. ACS Omega (2020) 5, 19557-19564. DOI:10.1021/acsomega.0c02027. https://pubmed.ncbi.nlm.nih.gov/32803050/ 

H.U. Shetty, S.S. Zoghbi, C.L. Morse, A. Kowalski, J. Hirvonen, R.B. Innis, V.W. Pike, Development of a non-radiometric method for measuring the arterial input function of a 11C-labeled PET radiotracer. Sci. Reports (2020) 10, article ID 17350. DOI:10.1038/s41598-020-73646-4. https://pubmed.ncbi.nlm.nih.gov/33060616/ 

Y. Wakabayashi, S. Telu, R.M. Dick, M. Fujita, M. Ooms, C.L. Morse, J-S. Liow, J.S. Hong, R.L. Gladding, L.S. Manly, S.S. Zoghbi, X. Mo, E.C. D’Amato, J.A. Sindac, R.A. Nugent, B.E. Marron, M.E. Gurney, V.W. Pike, Discovery, radiolabeling, and evaluation of subtype-selective inhibitors for positron emission tomography imaging of brain phosphodiesterase-4D. ACS Chem. Neurosci. (2020) 11, 1311-1323. DOI:10.1021/acschemneuro.0c00077. https://pubmed.ncbi.nlm.nih.gov/32212718/